ArticleFrontiers in oncology2026
Dosimetric comparison of TomoTherapy and non-coplanar VMAT for hippocampal-avoidance prophylactic cranial irradiation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the dosimetric characteristics of non-coplanar volumetric modulated arc therapy (VMAT) and TomoTherapy for hippocampal-avoidance prophylactic cranial irradiation (HA-PCI) in small cell lung cancer (SCLC) patients. Methods: Ten SCLC patients who received HA-PCI were retrospectively analyzed. Two plans were generated as TrueBeam non-coplanar VMAT with four arcs and helical TomoTherapy. The hippocampal avoidance zone used a 3-mm margin, reduced from RTOG 0933's 5-mm specification. Planning target volume of whole brain (PTV_WB) was prescribed 25 Gy in 10 fractions, normalized to D Results: Non-coplanar VMAT achieved significantly lower hippocampal D Conclusions: Non-coplanar VMAT demonstrated superior dosimetric characteristics compared to TomoTherapy for HA-PCI with 3-mm margin, meeting hippocampal constraints while improving target coverage and treatment efficiency. Prospective validation with neurocognitive outcomes is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.